Cargando…
Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002735/ http://dx.doi.org/10.1186/1750-9378-5-S1-A72 |
_version_ | 1782193774877736960 |
---|---|
author | Uldrick, Thomas Polizzotto, Mark O’Mahony, Deirdre Aleman, Karen Wyvill, Kathy Steinberg, Seth M Pittaluga, Stefania Marshall, Vickie Whitby, Denise Tosato, Giovanna Little, Richard F Yarchoan, Robert |
author_facet | Uldrick, Thomas Polizzotto, Mark O’Mahony, Deirdre Aleman, Karen Wyvill, Kathy Steinberg, Seth M Pittaluga, Stefania Marshall, Vickie Whitby, Denise Tosato, Giovanna Little, Richard F Yarchoan, Robert |
author_sort | Uldrick, Thomas |
collection | PubMed |
description | |
format | Text |
id | pubmed-3002735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30027352010-12-16 Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) Uldrick, Thomas Polizzotto, Mark O’Mahony, Deirdre Aleman, Karen Wyvill, Kathy Steinberg, Seth M Pittaluga, Stefania Marshall, Vickie Whitby, Denise Tosato, Giovanna Little, Richard F Yarchoan, Robert Infect Agent Cancer Meeting Abstracts BioMed Central 2010-10-11 /pmc/articles/PMC3002735/ http://dx.doi.org/10.1186/1750-9378-5-S1-A72 Text en Copyright ©2010 Uldrick et al; licensee BioMed Central Ltd. |
spellingShingle | Meeting Abstracts Uldrick, Thomas Polizzotto, Mark O’Mahony, Deirdre Aleman, Karen Wyvill, Kathy Steinberg, Seth M Pittaluga, Stefania Marshall, Vickie Whitby, Denise Tosato, Giovanna Little, Richard F Yarchoan, Robert Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) |
title | Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) |
title_full | Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) |
title_fullStr | Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) |
title_full_unstemmed | Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) |
title_short | Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) |
title_sort | rituximab combined with liposomal doxorubicin (r-dox) in hiv-infected patients with severe kaposi sarcoma-associated herpes virus (kshv) associated multicentric castleman disease (mcd) |
topic | Meeting Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002735/ http://dx.doi.org/10.1186/1750-9378-5-S1-A72 |
work_keys_str_mv | AT uldrickthomas rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT polizzottomark rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT omahonydeirdre rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT alemankaren rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT wyvillkathy rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT steinbergsethm rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT pittalugastefania rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT marshallvickie rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT whitbydenise rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT tosatogiovanna rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT littlerichardf rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd AT yarchoanrobert rituximabcombinedwithliposomaldoxorubicinrdoxinhivinfectedpatientswithseverekaposisarcomaassociatedherpesviruskshvassociatedmulticentriccastlemandiseasemcd |